MichaelMoncureMDFACS

General Surgery • Kansas City, MO

Trauma Surgery & Surgical Critical Care

Professor, General Surgery, University of Missouri Kansas City School of Medicine

Join to view full profile

Dr. Moncure is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Moncure's full profile

Already have an account?

Office
2301 Holmes St
Kansas City, MO 64108
Phone+1 816-404-5345

Education & Training

Howard University HospitalResidency, 1988 - 1993
University of Washington School of MedicineClass of 1988

Certifications & Licensure

MO State Medical License 2017 - 2025
KS State Medical License 1998 - 2018
NJ State Medical License 1994 - 1999
PA State Medical License 1995 - 1998
DC State Medical License 1991 - 1997
MD State Medical License 1993 - 1995
American Board of Surgery Surgery
American Board of Surgery Surgical Critical Care

Publications & Presentations

PubMed

2 citations
Efficacy and safety of phospholipid nanoparticles (VBI-S) in reversing intractable hypotension in patients with septic shock: a multicentre, open-label, repeated measu...
Cuthbert Simpkins, Michael Moncure, Heather Klepacz, Kristopher Roach, Sadia Benzaquen
Eclinicalmedicine. 2024-02-01
1 citations
Evaluating skills for psychological recovery with gunshot injury survivors in a hospital-based early intervention program.
Joah L Williams, Erin P Hambrick, Vivian L Gleason, Madeleine M Hardt, Aisling V Henschel
The American Journal of Orthopsychiatry. 2024-01-01
1 citations
Hospital-based PTSD risk screening and early mental health intervention for nonfatal gunshot victims.
Joah L Williams, Madeleine M Hardt, Aisling V Henschel, Salomé A Wilfred, Elizabeth J Wilson
General Hospital Psychiatry. 2022-07-25

Press Mentions

Vivacelle Bio Initiates Phase 3 Trial for Lead Asset VBI-S to Treat Patients with Hypovolemia Due to Septic ShockJuly 23rd, 2024